iPredict-DR
iHealthScreen
FDA cleareddiabetic retinopathydiabetes screening
AI software that screens color fundus images for more-than-mild diabetic retinopathy in adults with diabetes. FDA cleared in mid-2026; the company's AMD and glaucoma modules are not yet FDA cleared.
- Company
- iHealthScreen
- Category
- Screening
- Reads
- Color fundus photographs (iCare DRSplus camera named in iCare/Revenio announcement)
- Built for
- Primary care and eye clinics screening adults with diabetes
- Billing
- Check vendor
- Regulatory
- FDA 510(k) K253704, decision Jul 2, 2026, product code PIB. Company also reports CE and MHRA registration for its DR/AMD/glaucoma tools (not independently verified); an AMD 510(k) was reported as submitted, not cleared. · source
- Last verified
- 2026-10-07
DotAEye is independent of iHealthScreen. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.